News & Events about Syneos Health Inc.
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial SolutionsMORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Fosun Pharma ...
Mizuho downgraded shares of Syneos Health (NASDAQ:SYNH Get Rating) from a buy rating to a neutral rating in a research note issued to investors on Wednesday morning, The Fly reports. They currently have $38.00 price target on the stock, down from their prior price target of $66.00. The analysts ...
Tetris Pharma signs service agreement with Syneos Health Partnership to support Tetris Pharma roll-out of Ogluo across Europe 12 December 2022 Tetris Pharma Ltd (Tetris Pharma or the Company), a subsidiary of biopharmaceutical company, Arecor Therapeutics plc (AIM: AREC), today announces that it has...
Globe Newswire
2 months ago
Predicts AI and Machine Learning, Diversity and Medical Affairs willTransform Biopharma Product DevelopmentMORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends: ...
Forbes: Money
4 months ago
An awful day for the stock market leads to an overblown selloff and a great buying opportunity in shares of Syneos Health (SYNH).An awful day for the stock market leads to an overblown selloff and a great buying opportunity in shares of Syneos Health (SYNH...